Virus-like particle vaccine protects against H3N2 canine influenza virus in dog

Vaccine

Volumn 31, Issue 32, 2013, Pages 3268-3273

  Lee, Dong Hun ^a   Bae, Sang Woo ^a   Park, Jae Keun ^a   Kwon, Jung Hoon ^a   Yuk, Seong Su ^a   Song, Jae Min ^b   Kang, Sang Moo ^c   Kwon, Yong Kuk ^d   Kim, Hwi Yool ^a   Song, Chang Seon ^a  

^a Konkuk University   (South Korea)

^b Sungshin Women's University   (South Korea)

^c GEORGIA STATE UNIVERSITY   (United States)

^d Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

Author keywords

Canine influenza; H3N2; Vaccine; Virus like particle

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; MONTANIDE ISA 25; MONTANIDE ISA 51; PROTEIN M1; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION TEST; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BACULOVIRIDAE; DOGS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, VIRUS-LIKE PARTICLE; VIRAL MATRIX PROTEINS; VIRUS SHEDDING;

EID: 84879461148     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.023     Document Type: Article

References (27)

1. Crawford P.C., Dubovi E.J., Castleman W.L., Stephenson I., Gibbs E.P., Chen L., et al. Transmission of equine influenza virus to dogs. Science 2005, 310:482-485.
2. Payungporn S., Crawford P.C., Kouo T.S., Chen L.M., Pompey J., Castleman W.L., et al. Influenza A virus (H3N8) in dogs with respiratory disease, Florida. Emerg Infect Dis 2008, 14:902-908.
3. Li S., Shi Z., Jiao P., Zhang G., Zhong Z., Tian W., et al. Avian-origin H3N2 canine influenza A viruses in Southern China. Infect Genet Evol: J Mol Epidemiol Evol Genet Infect Dis 2010, 10:1286-1288.
4. Teng Q., Zhang X., Xu D., Zhou J., Dai X., Chen Z., et al. Characterization of an H3N2 canine influenza virus isolated from Tibetan mastiffs in China. Vet Microbiol 2012.
5. Song D., Lee C., Kang B., Jung K., Oh T., Kim H., et al. Experimental infection of dogs with avian-origin canine influenza A virus (H3N2). Emerg Infect Dis 2009, 15:56-58.
6. Song D., Kang B., Lee C., Jung K., Ha G., Kang D., et al. Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis 2008, 14:741-746.
7. Lee Y.N., Lee D.H., Park J.K., Yuk S.S., Nahm S.S., Lee J.B., et al. Experimental infection and natural contact exposure of ferrets with canine influenza virus (H3N2). J Gen Virol 2012.
8. Song D., Moon H.J., An D.J., Jeoung H.Y., Kim H., Yeom M.J., et al. A novel reassortant canine H3N1 influenza virus between pandemic H1N1 and canine H3N2 influenza viruses in Korea. J Gen Virol 2012, 93:551-554.
9. Kang S.M., Pushko P., Bright R.A., Smith G., Compans R.W. Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 2009, 333:269-289.
10. Haynes J.R. Influenza virus-like particle vaccines. Exp Rev Vaccines 2009, 8:435-445.
11. Perrone L.A., Ahmad A., Veguilla V., Lu X., Smith G., Katz J.M., et al. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009, 83:5726-5734.
12. Pushko P., Kort T., Nathan M., Pearce M.B., Smith G., Tumpey T.M. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Vaccine 2010, 28:4771-4776.
13. Song J.M., Hossain J., Yoo D.G., Lipatov A.S., Davis C.T., Quan F.S., et al. Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology 2010, 405:165-175.
14. Tao P., Luo M., Zhu D., Qu S., Yang Z., Gao M., et al. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice. Viral Immunol 2009, 22:273-281.
15. Lee D.H., Park J.K., Lee Y.N., Song J.M., Kang S.M., Lee J.B., et al. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine 2011, 29:4003-4007.
16. Park J.K., Lee D.H., Youn H.N., Kim M.S., Lee Y.N., Yuk S.S., et al. Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy. Influenza Other Respir Viruses 2012.
17. Kang S.M., Yoo D.G., Lipatov A.S., Song J.M., Davis C.T., Quan F.S., et al. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One 2009, 4:e4667.
18. Song J.M., Kim Y.C., Lipatov A.S., Pearton M., Davis C.T., Yoo D.G., et al. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol 2010, 17:1381-1389.
19. Spackman E., Senne D.A., Bulaga L.L., Myers T.J., Perdue M.L., Garber L.P., et al. Development of real-time RT-PCR for the detection of avian influenza virus. Avian Dis 2003, 47:1079-1082.
20. Quan F.S., Kim Y.C., Vunnava A., Yoo D.G., Song J.M., Prausnitz M.R., et al. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol 2010, 84:7760-7769.
21. Roldao A., Mellado M.C., Castilho L.R., Carrondo M.J., Alves P.M. Virus-like particles in vaccine development. Exp Rev Vaccines 2010, 9:1149-1176.
22. Quan F.S., Yoo D.G., Song J.M., Clements J.D., Compans R.W., Kang S.M. Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J Virol 2009, 83:4489-4497.
23. Song J.M., Choi C.W., Kwon S.O., Compans R.W., Kang S.M., Kim S.I. Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity. J Proteome Res 2011, 10:3450-3459.
24. Krammer F., Grabherr R. Alternative influenza vaccines made by insect cells. Trends Mol Med 2010, 16:313-320.
25. Margine I., Martinez-Gil L., Chou Y.Y., Krammer F. Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity. PLoS One 2012, 7:e51559.
26. Chang Y.F., Appel M.J., Jacobson R.H., Shin S.J., Harpending P., Straubinger R., et al. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi. Infect Immun 1995, 63:3543-3549.
27. Lee C., Jung K., Oh J., Oh T., Han S., Hwang J., et al. Protective efficacy and immunogenicity of an inactivated avian-origin H3N2 canine influenza vaccine in dogs challenged with the virulent virus. Vet Microbiol 2010, 143:184-188.